Radiology's Vikas Gulani weighed in on concerns surrounding gadolinium-based contrast agents

MEDIA | January 2, 2018
STORY BY: EDITORIAL STAFF

FDA issues tougher warning, additional research on MRI dye UPI: Vikas Gulani, associate professor of radiology, weighed in on the concerns surrounding whether gadolinium-based contrast agents, which are used in MRIs, are harmful to a patient.